Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9426972rdf:typepubmed:Citationlld:pubmed
pubmed-article:9426972lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9426972lifeskim:mentionsumls-concept:C0023449lld:lifeskim
pubmed-article:9426972lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:9426972lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:9426972lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:9426972lifeskim:mentionsumls-concept:C0439677lld:lifeskim
pubmed-article:9426972lifeskim:mentionsumls-concept:C0183683lld:lifeskim
pubmed-article:9426972pubmed:issue3lld:pubmed
pubmed-article:9426972pubmed:dateCreated1998-2-3lld:pubmed
pubmed-article:9426972pubmed:abstractTextThe effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3 and IL-6 on clonogenic growth of blast-cell progenitors from 19 immunologically defined CD10-positive B-lineage acute lymphoblastic leukemias (ALL) coexpressing (My+ALLs) or not (My-ALLs) myeloid antigens have been studied. Our results demonstrate that GM-CSF was able to support the clonogenic growth of blast cells from My+ALLs, being totally ineffective on My-All samples. Accordingly, both alpha and beta chains of GM-CSF receptor (R) were expressed by My+ALL blasts, as investigated by reverse-transcriptase polymerase chain reaction (RT-PCR). Colony cells from GM-CSF-stimulated My+ALL cultures displayed the same immunophenotype as primary leukemic cells at diagnosis (CD10+, CD19+, CD22+), and retained the expression of myeloid-associated antigens and of GM-CSF-R transcripts. Moreover, My+ALL blasts showed a preferential sensitivity to the growth-promoting activity of IL-3 and IL-6, as compared with My-ALL cells. In addition to rearrangements of the JH region of immunoglobulin genes, My+ALL cells showed aberrant rearrangements of gamma (three cases) and beta (two cases) T-cell receptor genes, as well as of bcr sequences (three cases). Our data, showing an unexpected cross-lineage response of My+ALLs to GM-CSF, and their preferential stimulation by IL-3 and IL-6, as compared with My-ALLs, further support the concept that My+ALLs represent a separate entity with unique biological features.lld:pubmed
pubmed-article:9426972pubmed:languageenglld:pubmed
pubmed-article:9426972pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9426972pubmed:citationSubsetIMlld:pubmed
pubmed-article:9426972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9426972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9426972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9426972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9426972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9426972pubmed:statusMEDLINElld:pubmed
pubmed-article:9426972pubmed:monthSeplld:pubmed
pubmed-article:9426972pubmed:issn1368-4736lld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:PintoAAlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:AttadiaVVlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:GatteiVVlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:ZagonelVVlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:AldinucciDDlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:DeganMMlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:RossiF MFMlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:BabareRRlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:De IuliisAAlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:RupoloMMlld:pubmed
pubmed-article:9426972pubmed:authorpubmed-author:AlosiM SMSlld:pubmed
pubmed-article:9426972pubmed:issnTypePrintlld:pubmed
pubmed-article:9426972pubmed:volume3lld:pubmed
pubmed-article:9426972pubmed:ownerNLMlld:pubmed
pubmed-article:9426972pubmed:authorsCompleteYlld:pubmed
pubmed-article:9426972pubmed:pagination141-51lld:pubmed
pubmed-article:9426972pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:meshHeadingpubmed-meshheading:9426972-...lld:pubmed
pubmed-article:9426972pubmed:year1997lld:pubmed
pubmed-article:9426972pubmed:articleTitleHuman granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens.lld:pubmed
pubmed-article:9426972pubmed:affiliationUnità Operativa Leucemie e Trapianto di Midollo, IRCCS, Aviano, Italy. vgattei@ets.itlld:pubmed
pubmed-article:9426972pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9426972pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed